2021 ASCO Virtual Scientific Meeting
Visit HTG's customer posters presented at the 2021 ASCO Virtual Scientific Meeting?
- Loibl, S., et al. Phase III study of palbociclib combined with endocrine therapy in patients with hormone-receptor-positive, HER2-negative primary breast cancer and high relapse risk after neoadjuvant chemotherapy: First results from PENELOPE-B
- Lopez-Guerrero, J. A., et al. MamaPred: a new and innovative approach to determine recurrence risk classification in luminal early-stage breast cancer using HTG EdgeSeq Technology.
- Jaramillo, M., et al. Gene expression profiling signatures for immunophenotyping of tumor microenvironment using HTG EdgeSeq Precision Immuno-Oncology Panel.
- Future Events